EVENT
Visit to Bio2Q by Dr. Hitoshi Nakagama, President of the Japan Agency for Medical Research and Development (AMED)
October 7, 2025
On September 22, 2025, Dr. Hitoshi Nakagama, President of the Japan Agency for Medical Research and Development (AMED), visited Bio2Q.
Administrative Director Oltea Sampetrean and others attended the meeting, introduced Bio2Q, exchanged opinions, and guided a tour of the facilities.
For more details, please see the report on the AMED website.
Visit report by AMED (in Japanese)
SHARE
More Bio2Q News
[Publication]M cell–dependent commensal uptake confers encephalitogenic phenotyp...
Co-authored by researchers from Bio2Q and Keio University, and published in Proceedings of the National Academy of Sciences (PNAS), this stu...
【Seminar Report】WPI-Bio2Q Open Seminar
Keio University Human Biology-Microbiome-Quantum Research Center (WPI-Bio2Q) held a seminar as follows. 17:00 -18:00 January 7, 2026 V...
[Publication]Niche-preserving transplantation promotes functional engraftment of...
Co-authored by Bio2Q and Keio University researchers, this study demonstrates a niche-preserving transplantation strategy that enables highl...
WPI-Bio2Q Newsletter "Bio2Q Connect" Vol. 2, Issue 12 Released
WPI-Bio2Q has released the latest issue of our newsletter, "Bio2Q Connect" (Vol. 2, Issue 12). This issue highlights the selection of six...
【Seminar】 WPI-Bio2Q Open Seminar: Tomoe Ishikawa, Ph.D.（for Keio Members）
Keio University Human Biology-Microbiome-Quantum Research Center (WPI-Bio2Q) will hold a seminar as follows. This event is only for faculty...
